LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 138

Search options

  1. Article ; Online: Time and change: Scientific publishing in a postpandemic environment.

    Wold, Loren E

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

    2023  Volume 37, Issue 8, Page(s) e23102

    Language English
    Publishing date 2023-07-25
    Publishing country United States
    Document type Editorial
    ZDB-ID 639186-2
    ISSN 1530-6860 ; 0892-6638
    ISSN (online) 1530-6860
    ISSN 0892-6638
    DOI 10.1096/fj.202301378
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Announcing the FASEB Journal Early Career Researcher Editorial Board and new peer review workflow.

    Henderson, Darla P / Wold, Loren E

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

    2024  Volume 38, Issue 1, Page(s) e23353

    Language English
    Publishing date 2024-01-05
    Publishing country United States
    Document type Editorial
    ZDB-ID 639186-2
    ISSN 1530-6860 ; 0892-6638
    ISSN (online) 1530-6860
    ISSN 0892-6638
    DOI 10.1096/fj.202302406
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The FASEB Journal and scientific integrity.

    Wold, Loren E / Botos, Jeannine / Henderson, Darla P

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

    2024  Volume 38, Issue 6, Page(s) e23540

    MeSH term(s) Societies, Scientific
    Language English
    Publishing date 2024-03-16
    Publishing country United States
    Document type Editorial
    ZDB-ID 639186-2
    ISSN 1530-6860 ; 0892-6638
    ISSN (online) 1530-6860
    ISSN 0892-6638
    DOI 10.1096/fj.202400402
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: FASEB BioAdvances

    Wold, Loren E / D'Souza-Schorey, Crislyn / Wong, Yung Hou

    FASEB bioAdvances

    2024  Volume 6, Issue 4, Page(s) 103–104

    Language English
    Publishing date 2024-03-20
    Publishing country United States
    Document type Editorial
    ISSN 2573-9832
    ISSN (online) 2573-9832
    DOI 10.1096/fba.2024-00043
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Editorial: Cardiovascular and renal 2020: Cardiovascular protection by antidiabetic drugs: Key mechanisms and current clinical data.

    Gorr, Matthew W / Wold, Loren E

    Current opinion in pharmacology

    2021  Volume 54, Page(s) vii–ix

    MeSH term(s) Animals ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/prevention & control ; Diabetes Complications/drug therapy ; Humans ; Hypoglycemic Agents/therapeutic use ; Kidney Diseases/etiology ; Kidney Diseases/prevention & control
    Chemical Substances Hypoglycemic Agents
    Language English
    Publishing date 2021-02-18
    Publishing country England
    Document type Editorial ; Introductory Journal Article
    ZDB-ID 2037057-X
    ISSN 1471-4973 ; 1471-4892
    ISSN (online) 1471-4973
    ISSN 1471-4892
    DOI 10.1016/j.coph.2020.12.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Electronic Nicotine Delivery Systems and Cardiovascular/Cardiometabolic Health.

    Mears, Matthew J / Hookfin, Harrison L / Bandaru, Priya / Vidal, Pablo / Stanford, Kristin I / Wold, Loren E

    Circulation research

    2023  Volume 132, Issue 9, Page(s) 1168–1180

    Abstract: The use of electronic nicotine delivery systems, specifically electronic cigarettes (e-cig), has risen dramatically within the last few years; the demographic purchasing these devices is now predominantly adolescents that are not trying to quit the use ... ...

    Abstract The use of electronic nicotine delivery systems, specifically electronic cigarettes (e-cig), has risen dramatically within the last few years; the demographic purchasing these devices is now predominantly adolescents that are not trying to quit the use of traditional combustible cigarettes, but rather are new users. The composition and appearance of these devices has changed since their first entry into the market in the late 2000s, but they remain composed of a battery and aerosol delivery system that is used to deliver breakdown products of propylene glycol/vegetable glycerin, flavorings, and potentially nicotine or other additives. Manufacturers have also adjusted the type of nicotine that is used within the liquid to make the inhalation more palatable for younger users, further affecting the number of youth who use these devices. Although the full spectrum of cardiovascular and cardiometabolic consequences of e-cig use is not fully appreciated, data is beginning to show that e-cigs can cause both short- and long-term issues on cardiac function, vascular integrity and cardiometabolic issues. This review will provide an overview of the cardiovascular, cardiometabolic, and vascular implications of the use of e-cigs, and the potential short- and long-term health effects. A robust understanding of these effects is important in order to inform policy makers on the dangers of e-cigs use.
    MeSH term(s) Humans ; Adolescent ; Nicotine/adverse effects ; Electronic Nicotine Delivery Systems ; Lung/metabolism ; Vaping/adverse effects ; Cardiovascular Diseases/epidemiology ; Cardiovascular Diseases/metabolism
    Chemical Substances Nicotine (6M3C89ZY6R)
    Language English
    Publishing date 2023-04-27
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 80100-8
    ISSN 1524-4571 ; 0009-7330 ; 0931-6876
    ISSN (online) 1524-4571
    ISSN 0009-7330 ; 0931-6876
    DOI 10.1161/CIRCRESAHA.123.321565
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Demographic and Behavioral Differences Between Adolescents and Young Adults Who Use E-Cigarettes at Low and High Frequency.

    Singer, Jill M / Tackett, Alayna P / Klein, Elizabeth G / Lu, Bo / Wagner, Dylan D / Wold, Loren E / Roberts, Megan E

    Substance use & addiction journal

    2024  Volume 45, Issue 2, Page(s) 232–239

    Abstract: Background: Among adolescents and young adults (AYAs), "current use" of electronic cigarettes (e-cigarettes) is commonly defined as any use in the past 30 days. However, few studies have examined differences among those within this broad category. This ... ...

    Abstract Background: Among adolescents and young adults (AYAs), "current use" of electronic cigarettes (e-cigarettes) is commonly defined as any use in the past 30 days. However, few studies have examined differences among those within this broad category. This study examined characteristics of AYAs who used e-cigarettes at a low frequency (within the last 3 months but <6 days out of the past 30 days) and those who used e-cigarettes at a high frequency (6+ days out of the past 30 days).
    Methods: We conducted cross-sectional analyses among 551 Ohio AYAs (15- to 24-year-olds) who reported using an e-cigarette to vape nicotine in the past 3 months. We used descriptive statistics and logistic regression to characterize those using e-cigarettes at a low frequency and a high frequency.
    Results: Among our sample of AYAs who reported past 3-month e-cigarette use, about half (50.8%) reported using an e-cigarette 6 or more days out of the past 30 days (ie, high frequency). In the multivariable analysis, reported nicotine dependence (Odds Ratio [OR]: 7.0, 95% CI: 4.8, 10.3) and current other tobacco product use (OR: 1.8, 95% CI: 1.1, 2.9) were associated with high-frequency e-cigarette use.
    Conclusion: Our results suggest that frequency of use is an important characteristic in understanding AYA e-cigarette use. Any use in the past 30 days may not be sensitive enough to understand dependence and tobacco-use behaviors. Further characterizing "current" e-cigarette use by frequency of use may provide meaningful information for public health professionals to better target intervention and cessation efforts to AYAs.
    MeSH term(s) Humans ; Adolescent ; Young Adult ; Electronic Nicotine Delivery Systems ; Cross-Sectional Studies ; Tobacco Use Disorder ; Vaping ; Demography
    Language English
    Publishing date 2024-01-02
    Publishing country United States
    Document type Journal Article
    ISSN 2976-7350
    ISSN (online) 2976-7350
    DOI 10.1177/29767342231214115
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Nicotine information disclosed online by e-cigarette brands popular with young people.

    Rykaczewski, Clara / Tackett, Alayna P / Klein, Elizabeth G / Singer, Jill M / Lu, Bo / Wold, Loren E / Wagner, Dylan D / Roberts, Megan E

    Tobacco prevention & cessation

    2024  Volume 10

    Abstract: Introduction: E-cigarette use is most prevalent among adolescents and young adults - and there are often misperceptions about product risk. The purpose of this study was to determine what nicotine information is provided on e-cigarette brand websites.!## ...

    Abstract Introduction: E-cigarette use is most prevalent among adolescents and young adults - and there are often misperceptions about product risk. The purpose of this study was to determine what nicotine information is provided on e-cigarette brand websites.
    Methods: Based on national and local surveys, we identified 44 e-cigarette brands commonly used in the US by adolescents and young adults. For each of these brands, their associated websites were analyzed for disclosed nicotine information. Specifically, for each brand's website, we coded whether there was information on nicotine concentration (recorded if a numerical value was provided such as '5% nicotine'), nicotine form (free-base, nicotine salts, or not stated), and nicotine type (tobacco-derived, synthetically derived, or not stated). Coding allowed for both lay (e.g. 'nic salts') as well as scientific (e.g. 'isomers') terms.
    Results: Of the 44 brands examined, all provided basic information on nicotine concentration (e.g. '5% nicotine'). However, 23% of brands did not disclose information on nicotine form (i.e. nicotine salt vs free-base), and 66% of brands did not disclose information on nicotine type (i.e. synthetic vs tobacco-derived).
    Conclusions: Overall, these results suggest that the e-cigarette industry is not fully informing its consumers about the nicotine in their products. Given that nicotine form and type have implications for e-cigarette addiction potential, these findings highlight a public health concern. There is a need for more comprehensive national regulations for mandating product constituents and emissions disclosures.
    Language English
    Publishing date 2024-04-25
    Publishing country Greece
    Document type Journal Article
    ISSN 2459-3087
    ISSN (online) 2459-3087
    DOI 10.18332/tpc/186953
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Basic Cardiovascular Sciences Scientific Sessions 2020: Emerging Opportunities in Cardiovascular Diseases.

    Sadayappan, Sakthivel / Tardiff, Jil C / Wold, Loren E

    Circulation research

    2020  Volume 127, Issue 11, Page(s) 1459–1467

    MeSH term(s) Animals ; Biomedical Research ; COVID-19 ; Cardiology ; Cardiovascular Diseases/diagnosis ; Cardiovascular Diseases/physiopathology ; Cardiovascular Diseases/therapy ; Congresses as Topic ; Coronavirus Infections ; Humans ; Information Dissemination ; Pandemics ; Pneumonia, Viral
    Keywords covid19
    Language English
    Publishing date 2020-11-05
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 80100-8
    ISSN 1524-4571 ; 0009-7330 ; 0931-6876
    ISSN (online) 1524-4571
    ISSN 0009-7330 ; 0931-6876
    DOI 10.1161/CIRCRESAHA.120.318257
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Double trouble: combined cardiovascular effects of particulate matter exposure and coronavirus disease 2019.

    Tanwar, Vineeta / Adelstein, Jeremy M / Wold, Loren E

    Cardiovascular research

    2020  Volume 117, Issue 1, Page(s) 85–95

    Abstract: The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly grown into a pandemic. According to initial reports, the lungs were thought to be the primary target, but recent case studies have ... ...

    Abstract The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly grown into a pandemic. According to initial reports, the lungs were thought to be the primary target, but recent case studies have shown its reach can extend to other organs including the heart and blood vessels. The severity of cardiac complications of COVID-19 depends on multiple underlying factors, with air pollutant exposure being one of them, as reported by several recent studies. Airborne particulate matter (PM) attracts heightened attention due to its implication in various diseases, especially respiratory and cardiovascular diseases. Inhaled PM not only carries microorganisms inside the body but also elicits local and systemic inflammatory responses resulting in altering the host's immunity and increasing susceptibility to infection. Previous and recent studies have documented that PM acts as a 'carrier' for the virus and aids in spreading viral infections. This review presents the mechanisms and effects of viral entry and how pollution can potentially modulate pathophysiological processes in the heart. We aimed to concisely summarize studies examining cardiovascular outcomes in COVID-19 patients and postulate on how PM can influence these outcomes. We have also reviewed evidence on the use of renin-angiotensin system inhibitors, namely angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, in patients with COVID-19. The interplay of pollution and SARS-CoV-2 is essential to understanding the effects of accentuated cardiovascular effects of COVID-19 and deserves in-depth experimental investigations.
    MeSH term(s) Angiotensin Receptor Antagonists/therapeutic use ; Angiotensin-Converting Enzyme 2/physiology ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; COVID-19/complications ; COVID-19/mortality ; Cardiovascular Diseases/etiology ; Humans ; Particulate Matter/toxicity ; SARS-CoV-2 ; Virus Internalization
    Chemical Substances Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors ; Particulate Matter ; ACE2 protein, human (EC 3.4.17.23) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23)
    Keywords covid19
    Language English
    Publishing date 2020-10-09
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 80340-6
    ISSN 1755-3245 ; 0008-6363
    ISSN (online) 1755-3245
    ISSN 0008-6363
    DOI 10.1093/cvr/cvaa293
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top